The Health Sciences Authority (HSA) has suspended
the license of Zerin® tablets 500mg due to product
defects.
The tablets, which are manufactured by Jayson Pharmaceuticals are
used for the relief of fever and pain, and are available as an
over-the counter medicine.
A HSA spokesman stressed that while the health risk posed by
consuming the tablets is low, the product is being taken off the
market due to non-compliance with quality standards.
Said the spokesman: "From HSA’s ongoing post marketing
surveillance, four reports of product defects were investigated
since August 2011 regarding Zerin® tablets, where some tablets from
different batches were found to contain small foreign
particles.
"HSA is currently working with Ziwell Medical and Jayson
Pharmaceuticals Ltd to ascertain the cause of the product defects
in Zerin® tablets. This includes a planned on-site audit of the
manufacturer to assess its facilities and processes, including the
review of possible root causes for the quality defects, as well as
any corrective and preventive actions taken to address the root
causes."
As an added precaution, HSA has also suspended the sale of
Histacin® (chlorpheniramine) 4mg tablets, an antihistamine by
Jayson Pharmaceutical.
Consumers who have stocks of Zerin® tablets are advised to stop
consuming the product.
Consumers who require paracetamol are advised to use any of the
more than ten alternative brands of paracetamol tablets available
in Singapore.
Alternatively, they could also seek the advice of their healthcare
providers.
oh no......... im gonna die......................